Description
CLOPINOX-A 75 Tablet is a fixed-dose combination of two antiplatelet agents used to reduce the risk of heart attack, stroke, and other vascular events in high-risk individuals, especially after stenting or with established vascular disease.
Dosage & Administration
-
Usual adult dose: 1 tablet (clopidogrel 75 mg + aspirin 75 mg) once daily, taken at the same time each day with food to minimize stomach upset and reduce gastrointestinal side effects.
-
Administration tips: Swallow whole with water; do not split, chew, or crush.
-
Should be taken regularly without missing doses; do not stop abruptly or without doctor’s advice, as this can increase thrombotic (clotting) risk.
Uses / Indications
-
Prevents heart attack, stroke, or other clot-related events in patients with:
-
Recent heart attack or stroke
-
Coronary artery stenting or bypass surgery
-
Peripheral arterial disease
-
High-risk stable or unstable angina or acute coronary syndrome.
-
-
Common as “dual antiplatelet therapy” for certain heart conditions and post-stent management.
Safety & Side Effects
-
Common: Heartburn, mild stomach upset, diarrhea, easy bruising, nosebleeds, increased risk of bleeding.
-
Serious/rare: Black stools, blood in urine/vomit, prolonged bleeding, severe stomach pain, allergic reactions—seek medical attention if these occur.
-
Not advised in severe liver/kidney impairment, active bleeding, or peptic ulcer disease.
-
May interact with other blood thinners, NSAIDs, PPIs, and some antidepressants—inform your doctor of all medications.
Special Precautions
-
Use caution with sharp objects and avoid activities with high trauma risk.
-
Inform all healthcare providers, including dentists, about the medication before procedures; temporary discontinuation may be required for surgery or dental work.
-
Not recommended in pregnancy or breastfeeding without medical advice.
Note:
CLOPINOX-A 75 is for long-term vascular prevention only under prescription. Regular follow-up and monitoring for bleeding or other side effects are important.
Leave a Reply